Want to see AVIR full AI Analyst Report?
Atea Pharmaceuticals (AVIR) Ownership Overview
11.27% Insiders
16.72% Mutual Funds
20.79% Other Institutional Investors
11.31% ETFs
39.91% Public Companies and
Individual Investors
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 48.83% of the company’s stock is owned by Institutional Investors, 11.27% is owned by Insiders, and 39.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 20, 2026 | xxxxxxxxxxxxx | $25437 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $75074 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,633,855 | Insider | 8.27% | 34,960,416 | |
| 4,388,875 | Institution | 5.47% | 23,129,371 | |
| 3,526,093 | Institution | 4.40% | 18,582,510 | |
| 3,522,841 | Institution | 4.39% | 18,565,372 | |
| 3,177,776 | Institution | 3.96% | 16,746,880 | |
| 823,576 | Insider | 1.03% | 4,340,246 | |
| 788,084 | Institution | 0.98% | 4,153,203 | |
| 763,875 | Institution | 0.95% | 4,025,621 | |
| 722,484 | Institution | 0.90% | 3,807,491 | |
| 690,702 | Institution | 0.86% | 3,640,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,388,875 | Institution | 5.47% | 23,129,371 | |
| 3,177,776 | Institution | 3.96% | 16,746,880 | |
| 788,084 | Institution | 0.98% | 4,153,203 | |
| 763,875 | Institution | 0.95% | 4,025,621 | |
| 722,484 | Institution | 0.90% | 3,807,491 | |
| 690,702 | Institution | 0.86% | 3,640,000 | |
| 489,864 | Institution | 0.61% | 2,581,583 | |
| 410,029 | Institution | 0.51% | 2,160,853 | |
| 261,130 | Institution | 0.33% | 1,376,155 | |
| 237,534 | Institution | 0.30% | 1,251,804 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,032,268 | Institution | 2.53% | 9,551,660 | |
| 1,792,905 | Institution | 2.24% | 9,448,609 | |
| 867,534 | Institution | 1.08% | 4,077,410 | |
| 664,891 | Institution | 0.83% | 3,503,976 | |
| 481,767 | Institution | 0.60% | 2,538,912 | |
| 397,379 | Institution | 0.50% | 1,867,681 | |
| 343,118 | Institution | 0.43% | 1,948,910 | |
| 263,930 | Institution | 0.33% | 1,499,122 | |
| 239,656 | Institution | 0.30% | 1,262,987 | |
| 234,809 | Institution | 0.29% | 1,091,862 |
FAQ
Who Owns Atea Pharmaceuticals (AVIR)?
According to the latest TipRanks data, approximately 20.79% of the company's stock is held by institutional investors, 11.27% is held by insiders, and 39.91% is held by retail investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.79% of Atea Pharmaceuticals (AVIR) stock is held by institutional investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.91% of Atea Pharmaceuticals (AVIR) stock is held by retail investors.
Who owns the most shares of Atea Pharmaceuticals (AVIR)?
Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals (AVIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.